The plasma CTS level was higher in individuals without CAD (1.38 ± 0.98 ng/mL; p = 0.001) than in the STEMI (0.80 ± 0.62 ng/mL) and UAP (0.99 ± 0.63 ng/mL) groups. This evidence concerns the gene TTR and coronary artery disorder.